In the last trading session, 8.4 million shares of the ReShape Lifesciences Inc (NASDAQ:RSLS) were traded, and its beta was 1.07. Most recently the company’s share price was $0.46, and it changed around -$0.11 or -18.53% from the last close, which brings the market valuation of the company to $5.21M. RSLS currently trades at a discount to its 52-week high of $29.00, offering almost -6204.35% off that amount. The share price’s 52-week low was $0.30, which indicates that the current value has risen by an impressive 34.78% since then. We note from ReShape Lifesciences Inc’s average daily trading volume that its 10-day average is 71.55 million shares, with the 3-month average coming to 12.57 million.
ReShape Lifesciences Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended RSLS as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. ReShape Lifesciences Inc is expected to report earnings per share of 0 for the current quarter.
ReShape Lifesciences Inc (NASDAQ:RSLS) trade information
Instantly RSLS has showed a red trend with a performance of -18.53% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.6977 on recent trading dayincreased the stock’s daily price by 34.07%. The company’s shares are currently down -89.65% year-to-date, but still up 0.35% over the last five days. On the other hand, ReShape Lifesciences Inc (NASDAQ:RSLS) is -27.31% down in the 30-day period. We can see from the shorts that 0.69 million shares have been sold at a short interest cover period of 1.14 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 80.05%.
RSLS Dividends
ReShape Lifesciences Inc’s next quarterly earnings report is expected to be released on 2025-Apr-03.
ReShape Lifesciences Inc (NASDAQ:RSLS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.11% of ReShape Lifesciences Inc shares, and 4.88% of them are in the hands of institutional investors. The stock currently has a share float of 5.09%.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 2.39 shares worth $1104.0, making up 0.02% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 860.0 shares worth around $396.0, which represents about 0.01% of the total shares outstanding.
